Market Indices
Latest News
| ||
| ||
| ||
|
Price Targets
from Susquehanna issued a price target of $140.00 for BIDU on 2026-05-20 11:07:23.The adjusted price target was set to $140.00.At the time of the announcement, BIDU was...
May 20, 2026 BIDU -1.80%
from Morgan Stanley issued a price target of $30.10 for ZTO on 2026-05-20 10:48:45.The adjusted price target was set to $30.10.At the time of the announcement, ZTO...
May 20, 2026 ZTO -2.29%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| SMMT Summit Therapeutics Inc. | 17.63
11.23% | ||||||||||||||||||
| WIMI WiMi Hologram Cloud Inc. | 1.66
9.93% | ||||||||||||||||||
| TLSA Tiziana Life Sciences Ltd | 1.51
9.42% | ||||||||||||||||||
| CAN Canaan Inc. | 0.46
9.21% | ||||||||||||||||||
| SLN Silence Therapeutics plc | 6.30
9.19% | ||||||||||||||||||
| IPHA Innate Pharma S.A. | 2.22
9.15% | ||||||||||||||||||
| VLRS Controladora Vuela CompaĆ | 6.66
8.21% | ||||||||||||||||||
| KZIA Kazia Therapeutics Limite | 13.01
7.70% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 11.23%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 0.94%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 TEVA 0.94%